The information in these press releases is accurate only as of the date of the particular press release. Theravance does not update press releases once they have been made public. Press releases may contain forward-looking statements and future events or actual results could differ materially from those projected in the forward-looking statements.
All Releases
| |
Theravance to Present at Investor Conferences in February 2012
Feb 1, 2012
|
26.6 KB |
|
| |
Theravance to Report Fourth Quarter and Full Year 2011 Financial Results on February 9, 2012
Jan 26, 2012
|
20.9 KB |
|
| |
GSK and Theravance announce initial outcomes from pivotal Phase III studies for once-daily RelovairTM* in COPD and asthma
Jan 9, 2012
|
131.7 KB |
|
| |
Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for VIBATIV® (telavancin) for Injection
Jan 6, 2012
|
81.6 KB |
|
| |
Theravance to Present at the 30th Annual J.P. Morgan Healthcare Conference
Dec 28, 2011
|
25.2 KB |
|
| |
Theravance Announces Initiation of Phase 2 Study with Its MARIN Compound, TD-9855, for the Treatment of ADHD
Dec 12, 2011
|
86.7 KB |
|
| |
Theravance Announces Positive Results from a Phase 2a Study of its LAMA Candidate, TD-4208, for the Treatment of COPD
Nov 14, 2011
|
132.6 KB |
|
| |
Theravance to Present at Investor Conferences in November 2011
Nov 1, 2011
|
26.6 KB |
|
| |
Theravance Reports Third Quarter 2011 Financial Results
Oct 27, 2011
|
81.1 KB |
|
| |
Theravance Announces Presentation of GSK Phase 2 Data for LAMA (GSK573719) at CHEST 2011
Oct 19, 2011
|
18.7 KB |
|
| |
Theravance to Report Third Quarter 2011 Financial Results on October 27, 2011
Oct 13, 2011
|
20.8 KB |
|
| |
Astellas and Theravance Announce European Marketing Authorization for VIBATIV( R ) for Nosocomial Pneumonia Caused by MRSA
Sep 15, 2011
|
84.6 KB |
|
| |
Theravance to Present at Investor Conferences in September 2011
Aug 24, 2011
|
19.7 KB |
|
| |
Theravance Reports Second Quarter 2011 Financial Results
Jul 28, 2011
|
79.2 KB |
|
| |
Theravance to Report Second Quarter 2011 Financial Results on July 28, 2011
Jul 14, 2011
|
20.9 KB |
|
| |
GSK and Theravance announce results of two pivotal Phase III studies for RelovairTM in COPD
Jun 2, 2011
|
116.5 KB |
|
| |
Theravance to Present at Investor Conferences in June 2011
May 24, 2011
|
25.3 KB |
|
| |
Astellas and Theravance Receive Positive Opinion from CHMP for European Approval of VIBATIV( TM ) for Nosocomial Pneumonia Caused by MRSA
May 20, 2011
|
99.5 KB |
|
| |
Theravance Reports First Quarter 2011 Financial Results
Apr 28, 2011
|
106.4 KB |
|
| |
Theravance to Webcast 2011 Annual Meeting of Stockholders on April 27, 2011
Apr 20, 2011
|
62.7 KB |
|
|
|
= add release to Briefcase
